WHO ICTRP trial

The Body and Brain in Irritable Bowel Syndrome (IBS) Study: Evaluating the…

ACTRN12624001042538 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12624001042538
Public title The Body and Brain in Irritable Bowel Syndrome (IBS) Study: Evaluating the effects of fructans on gastrointestinal symptoms in adults with mild to moderate IBS
Scientific title The Body and Brain in IBS Study: Evaluating the effects of fructans on gastrointestinal symptoms in adults with mild to moderate IBS
Primary sponsor Deakin University
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Irritable bowel syndrome; Irritable bowel syndrome;Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Interventions Participants will undertake 5 test phases, in random order, of approximately 7 days each in duration. Four of the test phases will begin with 3 consecutive days during which a test drink is consumed each day. These 3 days will be followed…
Registration date Aug 28, 2024
Target size 20
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations